BMY vs LSAK · P/E 17, rev $24.46B vs rev $659.7M
Bristol-Myers Squibb Company (BMY) versus Lesaka Technologies Inc (LSAK) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Lesaka Technologies Inc (LSAK) is a software - infrastructure company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported LSAK revenue for 2025-06-30 was $659.7M. Net income was -$87.6M. LSAK currently screens at market cap $433.8M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. LSAK currently screens at market cap $433.8M.
Not investment advice. Open the BMY and LSAK stock pages for the full models.
Not investment advice.